Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring
NCT02397317
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
RADIATION:
Multi-fraction SABR
Sponsor
University of Sydney
Collaborators
[object Object]